Schroder Investment Management Group / BMY
Schroder Investment Management Group’s Bristol-Myers Squibb Co Position
Does Schroder Investment Management Group own Bristol-Myers Squibb Co (BMY)? Yes — 12.24M shares worth $742M (+0.61% of its 13F portfolio) as of Q1 2026, down from 12.55M shares the prior filed quarter.
Position Value
$742M
Q1 2026
Shares
12.24M
% of Portfolio
+0.61%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 12.24M | $742M | +0.61% |
| Q4 2025 | 12.55M | $681M | +0.52% |
| Q3 2025 | 12.17M | $549M | +0.43% |
| Q2 2025 | 13.69M | $634M | +0.54% |
| Q1 2025 | 10.11M | $617M | +0.62% |
| Q4 2024 | 11.41M | $640M | +0.61% |
| Q3 2024 | 7.63M | $395M | +0.40% |
| Q2 2024 | 6.67M | $277M | +0.31% |
| Q1 2024 | 4.57M | $248M | +0.29% |
| Q4 2023 | 3.47M | $178M | +0.23% |
| Q3 2023 | 2.77M | $161M | +0.24% |
| Q2 2023 | 3.49M | $223M | +0.32% |
| Q1 2023 | 7.93M | $549M | +0.82% |
| Q4 2022 | 9.23M | $664M | +1.05% |
| Q3 2022 | 9.61M | $683M | +1.13% |
| Q2 2022 | 9.95M | $766M | +1.17% |
| Q1 2022 | 8.83M | $646M | +0.85% |
| Q4 2021 | 8.01M | $500M | +0.65% |
| Q3 2021 | 7.11M | $421M | +0.65% |
| Q2 2021 | 6.74M | $451M | +0.56% |
| Q1 2021 | 5.27M | $333M | +0.43% |
| Q4 2020 | 9.05M | $561M | +0.39% |
| Q3 2020 | 4.61M | $270M | +0.43% |
| Q2 2020 | 4.54M | $267M | +0.48% |
| Q1 2020 | 4.48M | $259M | +0.55% |
| Q4 2019 | 4.26M | $274M | +0.45% |
| Q3 2019 | 3.58M | $180M | +0.32% |
| Q2 2019 | 4.69M | $213M | +0.39% |
| Q1 2019 | 4.42M | $211M | +0.38% |
| Q4 2018 | 4.03M | $210M | +0.38% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Schroder Investment Management Group’s full portfolio or all institutional holders of BMY.